1. Home
  2. WHD vs RLAY Comparison

WHD vs RLAY Comparison

Compare WHD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cactus Inc.

WHD

Cactus Inc.

HOLD

Current Price

$53.23

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$19.56

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHD
RLAY
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.1B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
WHD
RLAY
Price
$53.23
$19.56
Analyst Decision
Buy
Strong Buy
Analyst Count
6
10
Target Price
$56.33
$19.50
AVG Volume (30 Days)
839.8K
4.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.00%
N/A
EPS Growth
18.99
31.78
EPS
0.19
N/A
Revenue
$1,079,051,000.00
$15,355,000.00
Revenue This Year
$43.92
N/A
Revenue Next Year
$6.83
$324.03
P/E Ratio
$276.84
N/A
Revenue Growth
N/A
53.44
52 Week Low
$33.30
$3.03
52 Week High
$64.30
$20.79

Technical Indicators

Market Signals
Indicator
WHD
RLAY
Relative Strength Index (RSI) 47.69 61.44
Support Level $52.51 $12.10
Resistance Level $54.78 N/A
Average True Range (ATR) 1.87 1.29
MACD 0.33 -0.06
Stochastic Oscillator 76.59 63.09

Price Performance

Historical Comparison
WHD
RLAY

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. It has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: